LKLudger Kolbe

Ludger Kolbe

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ludger Kolbe has a total of 120 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hyperpigmentation Agents

    by Tamara Rogers, Ludger Kolbe

  • Open Access

    Visible light induces skin darkening in vivo: comparative pilot studies reveal enhanced susceptibility in melasma and its mitigation by a human tyrosinase inhibitor

    by Tobias Mann, Kerstin Eggers, Tamara Rogers, Julia Riedel, Manuela Lütgens, Lisa Thiele, Nadine Möller, Julia M. Weise, Ludger Kolbe

    Melasma is a common and recurring disorder of hyperpigmentation, characterized by dark spots that are distributed on sun-exposed areas of the skin. Whereas studies on sun-induced skin pigmentation have concentrated on implications of ultraviolet (UV) radiation, the effect of visible light (VIS) was long considered negligible. Optically opaque, tinted face care products have shown to prevent darkening of melasma spots, leading to the hypothesis that VIS plays a role in hyperpigmentation. Here, we analyzed the effects of VIS on melasma, and investigated how skin reacts to the exposure of UV and VIS irradiation, both separately and combined. Furthermore, we examined the impact of daily treatment with the tyrosinase inhibitor isobutylamido thiazolyl resorcinol (Thiamidol) on repetitive VIS irradiation. We show that melasma lesions respond more strongly to VIS than perilesional skin and were more conspicuous after irradiation. Also, in healthy skin, VIS alone induced immediate pigment darkening and delayed tanning. However, compared to vehicle treatment, the tyrosinase inhibitor Thiamidol significantly reduced the VIS-induced darkening in healthy skin. Graphical abstract


  • Open Access

    Targeting Melanin Production: The Safety of Tyrosinase Inhibition

    by Steffen Erler, Ludger Kolbe, Abdulkarim Najjar, Andreas Schepky, Ahmed Kamal, Daniela Lange, Tamara Rogers

    Hyperpigmentation remains a persistent dermatological challenge with limited treatment options. Among available strategies, tyrosinase inhibition stands out as the current most effective and safest approach for suppressing melanin synthesis. Thiamidol exemplifies a targeted tyrosinase inhibitor developed over a decade of research, guided by rigorous toxicological evaluation. Although it contains a resorcinol moiety, Thiamidol is not a resorcinol derivative and acts through a distinct thiazole 2-amino moiety. In addition to its targeted mode of action of tyrosinase inhibition rather than inactivation, assessments of cytotoxicity and genotoxicity distinguish it from cosmetic and pharmaceutical active ingredients that form highly reactive ortho- or para-quinones. With further exclusion for off-target effects based on pharma profiling and exposure modeling, Thiamidol’s rapid metabolism and absence of bioaccumulation support its safety profile. While an inhibitory mechanism requires repeated application, this characteristic enhances the safety profile and establishes Thiamidol as a cosmetic ingredient rather than a pharmaceutical. In additional to confirmatory clinical studies for efficacy and skin compatibility, a study shows that the use of Thiamidol-containing products does not negatively impact the dermatological diagnostic accessibility of naevi, which is important for skin health monitoring.


  • Open Access

    Primary keratinocyte model of actinic keratosis reveals UV-induced DNA damage accumulation and persistent IFN signaling

    by Leonardo Elsbroek, Katja Reuschlein, Syrus Karsai, Anna Geueke, Mareike von Petersdorff-Campen, Martina Bresch, Volker Steinkraus, Peter Weisenseel, Peter Wolf, Marc Winnefeld, et al.


  • Open Access

    Mechanistic Insights into Tyrosinase-Catalyzed Metabolism of Hydroquinone: Implications for the Etiology of Exogenous Ochronosis and Cytotoxicity to Melanocytes

    by Shosuke Ito, Ludger Kolbe, Tamara Rogers, Tobias Mann, Gudrun Weets, Hitomi Tanaka, Tomoko Nishimaki-Mogami, Thierry Passeron, Makoto Ojika, Kazumasa Wakamatsu

    The metabolism of hydroquinone (HQ) by tyrosinase presents significant biochemical and dermatological challenges, particularly due to its association with adverse effects such as exogenous ochronosis (EO). Despite its widespread use in skin-lightening products, the detailed mechanistic pathways of HQ metabolism by tyrosinase remain inadequately understood. This study aims to elucidate the mechanistic insights into the tyrosinase-catalyzed metabolism of HQ, leading to the production of HQ-eumelanin (HQ-EM) and HQ-pheomelanin (HQ-PM). We employed HPLC analysis to detect key intermediates and final metabolites. Results show that mushroom tyrosinase catalyzes the hydroxylation of HQ to 2-hydroxyhydroquinone (HHQ) via the 2-hydroxybenzoquinone (HBQ) pathway, giving rise to HQ-EM. However, in the presence of cysteine, a shift from HBQ to the benzoquinone (BQ) pathway occurs, giving rise to HQ-PM. Hydroiodic acid hydrolysis of HQ-PM and subsequent HPLC-electrochemical analysis identified 4-aminophenol (AP) as degradation product, thereby serving as a novel marker to monitor HQ oxidation in vitro. These results indicate that HQ functions both as a “pseudo” substrate for tyrosinase—undergoing redox exchange with dopaquinone to form BQ—and as a true substrate, yielding HBQ. This dual role contributes to the formation of HQ-EM and HQ-PM. It would be possible that EO is caused by a continuous oxidation of HQ mediated by tyrosinase activity in the skin.


  • Open Access

    Exogenous ochronosis by hydroquinone is not caused by inhibition of homogentisate dioxygenase but potentially by tyrosinase-catalysed metabolism of hydroquinone

    by Shosuke Ito, Ludger Kolbe, Gudrun Weets, Tamara Rogers, Caroline Bushdid, Tomoko Nishimaki-Mogami, Hitomi Tanaka, Thierry Passeron, Makoto Ojika, Kazumasa Wakamatsu

    Background: Hydroquinone is widely used for its hypopigmenting effects in treating hyperpigmentation disorders. However, its topical application has been linked to adverse effects, notably exogenous ochronosis, raising concerns about its safety and mechanisms of action. Objectives: To elucidate the metabolic pathway of hydroquinone in human melanocytes and to clarify the role of tyrosinase in the development of exogenous ochronosis. Methods: We conducted an in vitro investigation using human tyrosinase to analyse the metabolism of hydroquinone. The study involved assessing the oxidation of hydroquinone in the presence of L-DOPA and L-cysteine, measuring the production of dopaquinone and its subsequent derivatives, including 2-S-cysteinyl–hydroquinone (Cys-HQ) and hydroquinone–pheomelanin (HQ-PM). Results: Our findings demonstrate that human tyrosinase effectively oxidizes hydroquinone primarily via dopaquinone, with L-cysteine facilitating the formation of Cys-HQ. Further oxidation of Cys-HQ leads to the production of HQ-PM. Notably, the results indicate that tyrosinase activity is crucial for the induction of exogenous ochronosis by hydroquinone. Additionally, while high-molecular-weight hydroquinone derivatives may remain within melanosomes, low-molecular-weight metabolites can penetrate the dermis, potentially triggering the polymerization of ochronotic particles similar to those seen in exogenous ochronosis. Conclusions: Tyrosinase plays a significant role in hydroquinone-induced exogenous ochronosis, suggesting that hydroquinone acts as a ‘pseudo’ substrate for this enzyme. The findings highlight the importance of using tyrosinase inhibitors to reduce the risk of exogenous ochronosis, while cautioning against other melanogenesis inhibitors that may have similar side effects.


  • A new in vitro approach for determining the water resistance of sunscreen products, validated by a blinded ring test

    by M. Pissavini, F. Pouradier, G. Wiener, M. Contier, L. Kolbe, L. Nogueira, P. Lapalud, G. Renner, P. J. Matts

    Despite limited consumer understanding of sunscreen labelling, product choice remains primarily driven by the labelled Sun Protection Factor (SPF), alongside UVA protection and water resistance claims. To ensure the reliability of these key parameters, validated and reproducible testing methods are essential. In response to recent ISO publications on in vivo water resistance evaluation, the Cosmetics Europe Sun Protection Methods Task Force has initiated the development of a robust in vitro alternative. Current in vitro approaches are based on thin‐film UV transmittance techniques, but their accuracy is highly sensitive to film homogeneity, both during application and after immersion. It has been shown that immersion can induce film rearrangement, altering UV absorbance without necessarily reducing active ingredient content. This may lead to atypical results, including apparent increases in SPF values post‐immersion. Here, in a ring‐testing approach, we investigate a new method for determining the in vitro water resistance of sunscreen products. This study aims to identify the most robust and predictive in vitro alternative, contributing to the development of a standardized and scientifically reliable method for water resistance assessment in sunscreen products.


  • Open Access

    Effective reduction of post‐inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido‐thiazolyl‐resorcinol (Thiamidol)

    by Dennis Roggenkamp, Ncoza Dlova, Tobias Mann, Jan Batzer, Julia Riedel, Martina Kausch, Ivica Zoric, Ludger Kolbe

    Objective: Post‐inflammatory hyperpigmentation (PIH) is a major cosmetic concern especially in individuals with darker skin complexion. Unfortunately, treatment with anti‐inflammatory ingredients alone does not prevent the development of hyperpigmented spots. Recently, isobutylamido‐thiazolyl‐resorcinol (Thiamidol) was described as a very potent inhibitor of human tyrosinase. The objective of this research was to investigate the potential of this compound to prevent PIH induced by epidermal wounding (suction blister) and related to acne.Methods: Suction blister‐induced PIH was treated with a formulation containing Thiamidol or a vehicle for 3 months, and the changes in hyperpigmentation were monitored by spectroscopic measurements. The effect of skin care formulations containing Thiamidol on acne‐related PIH was investigated in two studies, a vehicle‐controlled, double‐blinded, randomized clinical study and a clinical observational study. Both studies had a duration of 3 months and included assessments such as clinical photography, clinical grading and melanin index measurements.Results: Already after 2 weeks of treatment, suction blister sites treated with Thiamidol were significantly lighter than control sites and improved throughout the treatment period. Subjects´ self‐grading demonstrated that Thiamidol significantly improved the visibility of acne‐induced hyperpigmentation compared to the vehicle treatment. A skin care regimen with Thiamidol significantly improved acne‐related PIH over 12 weeks shown by Mexameter measurements, expert grading, self‐grading and clinical photography.Conclusion: Thiamidol represents a safe and effective ingredient for cosmetic products against post‐inflammatory hyperpigmentation.


  • Open Access

    Concomitant DNA methylation and transcriptome signatures define epidermal responses to acute solar UV radiation

    by Nicholas Holzscheck, Jörn Söhle, Torsten Schläger, Cassandra Falckenhayn, Elke Grönniger, Ludger Kolbe, Horst Wenck, Lara Terstegen, Lars Kaderali, Marc Winnefeld, et al.

    The simultaneous analysis of different regulatory levels of biological phenomena by means of multi-omics data integration has proven an invaluable tool in modern precision medicine, yet many processes ultimately paving the way towards disease manifestation remain elusive and have not been studied in this regard. Here we investigated the early molecular events following repetitive UV irradiation of in vivo healthy human skin in depth on transcriptomic and epigenetic level. Our results provide first hints towards an immediate acquisition of epigenetic memories related to aging and cancer and demonstrate significantly correlated epigenetic and transcriptomic responses to irradiation stress. The data allowed the precise prediction of inter-individual UV sensitivity, and molecular subtyping on the integrated post-irradiation multi-omics data established the existence of three latent molecular phototypes. Importantly, further analysis suggested a form of melanin-independent DNA damage protection in subjects with higher innate UV resilience. This work establishes a high-resolution molecular landscape of the acute epidermal UV response and demonstrates the potential of integrative analyses to untangle complex and heterogeneous biological responses.


  • Open Access

    Validation of a new in vitro Sun Protection Factor method to include a wide range of sunscreen product emulsion types

    by M. Pissavini, C. Tricaud, G. Wiener, A. Lauer, M. Contier, L. Kolbe, C. Trullás Cabanas, F. Boyer, E. Meredith, J de Lapuente, et al.

    In 2017, Cosmetics Europe performed a double‐blinded ring test of 24 emulsion‐type sunscreen products, across 3 in vivo test laboratories and 3 in vitro test laboratories, using a new candidate in vitro SPF test method. Based on the results of this work, an article was published showing how data derived from a new lead candidate method conform to new International Standards (ISO) acceptance criteria for alternative SPF test methods (Any alternative method should consider the matrix effect and if required, specify the matrix applicability of the method; Criterion 1a: Systematic differences between methods should be negligible: 95% of all individual results of an alternative method are within the range of ±2× reproducibility standard deviation of the in vivo method, that is overall bias must be below 0.5× reproducibility standard deviation of the in vivo method; Criterion 1b: Measurement uncertainty of an alternative method should be below the measurement uncertainty of the in vivo method. Candidate method predicted values must fall within the full ‘funnel’ (SPF 6‐50+) limits proposed by Cosmetics Europe (derived from the same minimum test design, that is using the ISO24444 Method to measure at least 24 products across at least 3 laboratories using at least 5 test subjects/laboratory, in a blinded fashion).). Of the 24 sunscreen products tested, the majority of emulsions were of the oil‐in‐water (O/W) type, whereas only one was water‐in‐oil (W/O) and there were no products with a mineral‐only sun filter system. In order to confirm the scope of this method, therefore, a new study was conducted that included 73 W/O (12 mineral + organic, 44 mineral only and 17 organic only) and 3 O/W mineral‐only, emulsion‐type sunscreen products (a total of 76 new sunscreen products). When combined with the previous 24 products (tested in 3 different laboratories), this yielded a new data set comprising a total of 100 emulsion‐type sunscreen products, with SPF values ranging from 6 to 50+ (with a total of 148 data points). These products were tested using the double‐plate in vitro SPF test method and compared with the ISO TC217/WG7 acceptance criteria for alternative SPF test methods. Over 95% of paired in vitro: in vivo SPF values lay within the upper and lower limits of the ISO acceptance criteria funnel, with no bias. This new in vitro SPF test method, therefore, meets the minimum requirements for an alternative SPF test method to ISO24444:2010, for emulsion‐type sunscreen products (which make up the majority of marketed sunscreen products).